rs148912436

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6BS2_Supporting

The NM_003126.4(SPTA1):ā€‹c.1958A>Gā€‹(p.Tyr653Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00995 in 1,614,078 control chromosomes in the GnomAD database, including 90 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y653H) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.0080 ( 2 hom., cov: 32)
Exomes š‘“: 0.010 ( 88 hom. )

Consequence

SPTA1
NM_003126.4 missense

Scores

3
9
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:7

Conservation

PhyloP100: 7.39
Variant links:
Genes affected
SPTA1 (HGNC:11272): (spectrin alpha, erythrocytic 1) This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012779087).
BP6
Variant 1-158667938-T-C is Benign according to our data. Variant chr1-158667938-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 258918.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=2, Benign=3}. Variant chr1-158667938-T-C is described in Lovd as [Benign]. Variant chr1-158667938-T-C is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAd4 at 2 AD,AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SPTA1NM_003126.4 linkuse as main transcriptc.1958A>G p.Tyr653Cys missense_variant 15/52 ENST00000643759.2 NP_003117.2 P02549-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SPTA1ENST00000643759.2 linkuse as main transcriptc.1958A>G p.Tyr653Cys missense_variant 15/52 NM_003126.4 ENSP00000495214.1 P02549-1

Frequencies

GnomAD3 genomes
AF:
0.00804
AC:
1223
AN:
152160
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00244
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.0114
Gnomad ASJ
AF:
0.00749
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.00649
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0117
Gnomad OTH
AF:
0.0120
GnomAD3 exomes
AF:
0.00814
AC:
2030
AN:
249402
Hom.:
13
AF XY:
0.00804
AC XY:
1088
AN XY:
135302
show subpopulations
Gnomad AFR exome
AF:
0.00245
Gnomad AMR exome
AF:
0.00759
Gnomad ASJ exome
AF:
0.00854
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00284
Gnomad FIN exome
AF:
0.00728
Gnomad NFE exome
AF:
0.0118
Gnomad OTH exome
AF:
0.0116
GnomAD4 exome
AF:
0.0102
AC:
14843
AN:
1461800
Hom.:
88
Cov.:
32
AF XY:
0.00987
AC XY:
7175
AN XY:
727200
show subpopulations
Gnomad4 AFR exome
AF:
0.00185
Gnomad4 AMR exome
AF:
0.00731
Gnomad4 ASJ exome
AF:
0.00792
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00308
Gnomad4 FIN exome
AF:
0.00867
Gnomad4 NFE exome
AF:
0.0115
Gnomad4 OTH exome
AF:
0.0105
GnomAD4 genome
AF:
0.00802
AC:
1221
AN:
152278
Hom.:
2
Cov.:
32
AF XY:
0.00778
AC XY:
579
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.00243
Gnomad4 AMR
AF:
0.0113
Gnomad4 ASJ
AF:
0.00749
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00270
Gnomad4 FIN
AF:
0.00649
Gnomad4 NFE
AF:
0.0117
Gnomad4 OTH
AF:
0.0118
Alfa
AF:
0.0111
Hom.:
14
Bravo
AF:
0.00810
TwinsUK
AF:
0.0132
AC:
49
ALSPAC
AF:
0.0119
AC:
46
ESP6500AA
AF:
0.00268
AC:
10
ESP6500EA
AF:
0.0102
AC:
84
ExAC
AF:
0.00809
AC:
978
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.0120
EpiControl
AF:
0.0141

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenSep 01, 2024SPTA1: BS1, BS2 -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 13, 2023- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 22, 2023- -
not specified Benign:2
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesApr 11, 2016- -
Hereditary spherocytosis type 3 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Pyropoikilocytosis, hereditary Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Elliptocytosis 2 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Uncertain
-0.080
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.53
D;D
Eigen
Uncertain
0.30
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.92
.;D
MetaRNN
Benign
0.013
T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Uncertain
2.2
M;M
PrimateAI
Uncertain
0.52
T
PROVEAN
Pathogenic
-6.9
D;.
REVEL
Uncertain
0.34
Sift
Benign
0.070
T;.
Sift4G
Pathogenic
0.0010
D;.
Polyphen
0.75
P;P
Vest4
0.80
MVP
0.82
MPC
0.24
ClinPred
0.024
T
GERP RS
5.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.23
gMVP
0.29

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs148912436; hg19: chr1-158637728; COSMIC: COSV63748984; API